Company Search:
Advanced Search
Sponsored Links
Vernalis Plc Company Snapshot
Vernalis Plc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vernalis Plc with three other companies in this sector in the United Kingdom: GW Pharmaceuticals PLC (2016 sales of £10.32 million [US$13.28 million] of which 63% was Commercial), Midatech Pharma PLC (£6.92 million [US$8.91 million] of which 81% was Commercial), and MaxCyte Inc (£9.13 million [US$11.75 million] of which 100% was Medical Service).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Vernalis Plc
  Stock Performance Chart for Vernalis Plc
  Stock Data: Recent Stock Performance:
  Current Price (8/18/2017): 17.00p
(Figures in Pounds Sterling)
1 Week 3.8%   13 Weeks -10.5%  
4 Weeks -3.5%   52 Weeks -60.9%  
Vernalis Plc Key Data:
  Ticker: VER Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 12,034,000
(Year Ending Jan 2017).
Employees: 103
  Currency: Pounds Sterling Market Cap: 89,495,689
  Fiscal Yr Ends: June Shares Outstanding: 526,445,230
  Share Type: Ordinary Closely Held Shares: 6,837,974
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.